Item 7.01. Regulation FD Disclosure.
Jasper Therapeutics, Inc. (the “Company”) is furnishing an updated corporate
presentation, attached as Exhibit 99.1 to this Current Report on Form 8-K (the
“Corporate Presentation”), which the Company intends to post on the Company’s
website. The Corporate Presentation is current as of January 24, 2023, and the
Company disclaims any obligation to update this material in the future.
The information in this Item 7.01, including the Corporate Presentation attached
hereto as Exhibit 99.1, is being furnished under Item 7.01 of Form 8-K and shall
not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act
of 1934, as amended (the “Exchange Act”), or otherwise subject to the
liabilities of that section, and it shall not be deemed incorporated by
reference in any filing under the Securities Act of 1933, as amended, or the
Exchange Act, except as shall be expressly set forth by specific reference in
such a filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits. Exhibit No. Description 99.1 Corporate Presentation, dated January 2023. 104 Cover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL). 1
© Edgar Online, source Glimpses